162 related articles for article (PubMed ID: 14990422)
1. Cervical screening in the National Breast and Cervical Cancer Early Detection Program, 1995-2001.
Benard VB; Eheman CR; Lawson HW; Blackman DK; Anderson C; Helsel W; Thames SF; Lee NC
Obstet Gynecol; 2004 Mar; 103(3):564-71. PubMed ID: 14990422
[TBL] [Abstract][Full Text] [Related]
2. Cervical cancer screening among low-income women: results of a national screening program, 1991-1995.
Lawson HW; Lee NC; Thames SF; Henson R; Miller DS
Obstet Gynecol; 1998 Nov; 92(5):745-52. PubMed ID: 9794662
[TBL] [Abstract][Full Text] [Related]
3. Race-specific results of Papanicolaou testing and the rate of cervical neoplasia in the National Breast and Cervical Cancer Early Detection Program, 1991-1998 (United States).
Benard VB; Lee NC; Piper M; Richardson L
Cancer Causes Control; 2001 Jan; 12(1):61-8. PubMed ID: 11227926
[TBL] [Abstract][Full Text] [Related]
4. Screening histories of women with CIN 2/3 compared with women diagnosed with invasive cervical cancer: a retrospective analysis of the Norwegian Coordinated Cervical Cancer Screening Program.
Nygård JF; Nygård M; Skare GB; Thoresen SØ
Cancer Causes Control; 2005 May; 16(4):463-74. PubMed ID: 15953989
[TBL] [Abstract][Full Text] [Related]
5. Incidence of cervical intraepithelial neoplasia grade III, and cancer of the cervix uteri following a negative Pap-smear in an opportunistic screening.
Gram IT; Macaluso M; Stalsberg H
Acta Obstet Gynecol Scand; 1998 Feb; 77(2):228-32. PubMed ID: 9512333
[TBL] [Abstract][Full Text] [Related]
6. Three-year risk of high-grade CIN for women aged 30 years or older who undergo baseline Pap cytology and HPV co-screening.
Guo M; Khanna A; Wang J; Dawlett MA; Kologinczak TL; Lyons GR; Bassett RL; Sneige N; Gong Y; Bevers TB
Cancer Cytopathol; 2017 Aug; 125(8):644-651. PubMed ID: 28498639
[TBL] [Abstract][Full Text] [Related]
7. Implementing recommendations for the early detection of breast and cervical cancer among low-income women.
Lawson HW; Henson R; Bobo JK; Kaeser MK
MMWR Recomm Rep; 2000 Mar; 49(RR-2):37-55. PubMed ID: 15580731
[TBL] [Abstract][Full Text] [Related]
8. Cervical cancer screening in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) in four US-Affiliated Pacific Islands between 2007 and 2015.
Senkomago V; Royalty J; Miller JW; Buenconsejo-Lum LE; Benard VB; Saraiya M
Cancer Epidemiol; 2017 Oct; 50(Pt B):260-267. PubMed ID: 29120834
[TBL] [Abstract][Full Text] [Related]
9. Pap smear screening in women under 30 in the Norwegian Coordinated Cervical Cancer Screening Program, with a comparison of immediate biopsy vs Pap smear triage of moderate dysplasia.
Nygård JF; Nygård M; Skare GB; Thoresen SO
Acta Cytol; 2006; 50(3):295-302. PubMed ID: 16780024
[TBL] [Abstract][Full Text] [Related]
10. Papanicolaou smear findings in solid-organ transplant recipients compared with normal subjects according to the Bethesda 2001 system.
Ok Atılgan A; Tepeoğlu M; Haberal AN; Durukan E; Kuşcu E; Haberal M
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():219-22. PubMed ID: 25894158
[TBL] [Abstract][Full Text] [Related]
11. Meeting the cervical cancer screening needs of underserved women: the National Breast and Cervical Cancer Early Detection Program, 2004-2006.
Tangka FK; O'Hara B; Gardner JG; Turner J; Royalty J; Shaw K; Sabatino S; Hall IJ; Coates RJ
Cancer Causes Control; 2010 Jul; 21(7):1081-90. PubMed ID: 20361353
[TBL] [Abstract][Full Text] [Related]
12. The Italian experience of a Pap test and speculoscopy based screening programme.
Boselli F; De Martis S; Rivasi F; Toni A; Abbiati R; Chiossi G
J Med Screen; 2000; 7(3):160-2. PubMed ID: 11126166
[TBL] [Abstract][Full Text] [Related]
13. Follow-up findings in young females with high-grade squamous intraepithelial lesion papanicolaou test results.
Zhao C; Kalposi-Novak P; Austin RM
Arch Pathol Lab Med; 2011 Mar; 135(3):361-4. PubMed ID: 21366461
[TBL] [Abstract][Full Text] [Related]
14. Cervical neoplasia in pap smears: risk of cervical intra-epithelial neoplasia (CIN) after negative or no prior smears in a population without a mass screening programme.
Forsmo S; Jacobsen BK; Stalsberg H
Int J Epidemiol; 1996 Feb; 25(1):53-8. PubMed ID: 8666505
[TBL] [Abstract][Full Text] [Related]
15. Cervical cancer screening in medically underserved California Latina and non-Latina women: effect of age and regularity of Pap testing.
Howell LP; Gurusinghe S; Tabnak F; Sciortino S
Cancer Detect Prev; 2009; 32(5-6):372-9. PubMed ID: 19264426
[TBL] [Abstract][Full Text] [Related]
16. Risk of high-grade cervical intraepithelial neoplasia among young women with abnormal screening cytology.
Massad SL; Markwell S; Cejtin HE; Collins Y
J Low Genit Tract Dis; 2005 Oct; 9(4):225-9. PubMed ID: 16205193
[TBL] [Abstract][Full Text] [Related]
17. Screening capacity and cost-effectiveness of the human papillomavirus test versus cervicography as an adjunctive test to Pap cytology to detect high-grade cervical dysplasia.
Song T; Seong SJ; Lee SK; Kim BR; Ju W; Kim KH; Nam K; Sim JC; Kim TJ
Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():112-116. PubMed ID: 30682600
[TBL] [Abstract][Full Text] [Related]
18. Patients with negative cervical biopsies after papanicolaou test interpretations of "atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion": comparative longitudinal follow-up.
Huitron S; Bonvicino A; Fadare O
Ann Diagn Pathol; 2008 Jun; 12(3):187-90. PubMed ID: 18486894
[TBL] [Abstract][Full Text] [Related]
19. High-grade cervical abnormalities and cervical cancer in women following a negative Pap smear with and without an endocervical component: a cohort study with 10 years of follow-up.
Sultana F; English DR; Simpson JA; Canfell K; Gertig DM; Saville M
Int J Cancer; 2014 Sep; 135(5):1213-9. PubMed ID: 24488882
[TBL] [Abstract][Full Text] [Related]
20. Papanicolaou screening in an urgent care setting.
Dunn TS; Jazbec A; Awad R; Batal H
Am J Obstet Gynecol; 2005 Apr; 192(4):1084-6. PubMed ID: 15846184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
